• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天免疫受体:代谢性疾病进展的关键调节因子。

Innate immune receptors: key regulators of metabolic disease progression.

机构信息

Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.

Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Howard Hughes Medical Institute.

出版信息

Cell Metab. 2013 Jun 4;17(6):873-882. doi: 10.1016/j.cmet.2013.05.011.

DOI:10.1016/j.cmet.2013.05.011
PMID:23747246
Abstract

The study of the intersection of immunology and metabolism is a growing field fueled by the increased prevalence of obesity-associated pathologies. Importantly, the capacity of the innate immune system to sense metabolic stress induced by nutritional surplus has been linked with the progression of obesity, insulin resistance, type 2 diabetes mellitus, nonalcoholic fatty liver disease, and atherosclerosis. Moreover, it is clear that the innate immune system regulates the composition of the intestinal microbiota, which impacts multiple host metabolic processes. Here we review recent studies in this emerging field with an emphasis on how innate immune receptors determine metabolic disease progression.

摘要

免疫与代谢的交叉研究是一个日益增长的领域,这主要归因于肥胖相关病理的普遍增加。重要的是,先天免疫系统对营养过剩引起的代谢应激的感知能力与肥胖、胰岛素抵抗、2 型糖尿病、非酒精性脂肪性肝病和动脉粥样硬化的进展有关。此外,先天免疫系统调节肠道微生物组的组成,从而影响多种宿主代谢过程,这一点已很明确。在此,我们对这一新兴领域的最新研究进行综述,重点介绍先天免疫受体如何决定代谢性疾病的进展。

相似文献

1
Innate immune receptors: key regulators of metabolic disease progression.先天免疫受体:代谢性疾病进展的关键调节因子。
Cell Metab. 2013 Jun 4;17(6):873-882. doi: 10.1016/j.cmet.2013.05.011.
2
Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease.饮食、共生菌和肠道作为动脉粥样硬化、2 型糖尿病和非酒精性脂肪性肝病中病原体相关分子模式的来源。
Atherosclerosis. 2011 May;216(1):1-6. doi: 10.1016/j.atherosclerosis.2011.02.043. Epub 2011 Feb 26.
3
Immunologic impact of the intestine in metabolic disease.肠道在代谢性疾病中的免疫影响。
J Clin Invest. 2017 Jan 3;127(1):33-42. doi: 10.1172/JCI88879.
4
Innate immune activation in obesity.肥胖中的固有免疫激活。
Mol Aspects Med. 2013 Feb;34(1):12-29. doi: 10.1016/j.mam.2012.10.002. Epub 2012 Oct 13.
5
Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation.肥胖与糖尿病的免疫代谢:微生物群将肠道中分隔的免疫与代谢组织炎症联系起来。
Clin Sci (Lond). 2015 Dec;129(12):1083-96. doi: 10.1042/CS20150431.
6
Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis.超越胰岛素抵抗:非酒精性脂肪性肝炎中的固有免疫
Hepatology. 2008 Aug;48(2):670-8. doi: 10.1002/hep.22399.
7
The Intestinal Immune System in Obesity and Insulin Resistance.肥胖与胰岛素抵抗中的肠道免疫系统
Cell Metab. 2016 Mar 8;23(3):413-26. doi: 10.1016/j.cmet.2016.01.003. Epub 2016 Feb 4.
8
Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.了解并调节2型糖尿病中Toll样受体(TLRs)和NOD样受体(NLRs)的相互作用。
Curr Diabetes Rev. 2014 May;10(3):190-200. doi: 10.2174/1573399810666140515112609.
9
The intestinal microbiota in chronic liver disease.慢性肝脏疾病中的肠道微生物群。
Adv Immunol. 2013;117:73-97. doi: 10.1016/B978-0-12-410524-9.00003-7.
10
Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases.先天性免疫信号在非酒精性脂肪性肝病和心血管疾病中的作用。
Annu Rev Pathol. 2019 Jan 24;14:153-184. doi: 10.1146/annurev-pathmechdis-012418-013003. Epub 2018 Sep 19.

引用本文的文献

1
Non-linear relationship between Dietary Inflammatory Index and constipation: threshold identification and insights from NHANES [2005-2010] and Mendelian randomization analysis.饮食炎症指数与便秘之间的非线性关系:阈值识别以及来自美国国家健康和营养检查调查(2005 - 2010年)和孟德尔随机化分析的见解
Transl Gastroenterol Hepatol. 2025 Mar 14;10:25. doi: 10.21037/tgh-24-99. eCollection 2025.
2
A Perceived Dissociation Between Systemic Chronic Inflammation, Age, and the Telomere/Telomerase System in Type 2 Diabetes.2型糖尿病中全身慢性炎症、年龄与端粒/端粒酶系统之间的一种感知解离
Biomedicines. 2025 Feb 20;13(3):531. doi: 10.3390/biomedicines13030531.
3
Applications of Cyclodextrin-Based Drug Delivery Systems in Inflammation-Related Diseases.
基于环糊精的药物递送系统在炎症相关疾病中的应用
Pharmaceutics. 2025 Mar 17;17(3):378. doi: 10.3390/pharmaceutics17030378.
4
Guardians under Siege: Exploring Pollution's Effects on Human Immunity.守护者遭遇围攻:探索污染对人类免疫的影响。
Int J Mol Sci. 2024 Jul 16;25(14):7788. doi: 10.3390/ijms25147788.
5
Cohort profile: the 'Biomarkers of heterogeneity in type 1 diabetes' study-a national prospective cohort study of clinical and metabolic phenotyping of individuals with long-standing type 1 diabetes in the Netherlands.队列特征描述:“1 型糖尿病异质性的生物标志物”研究——荷兰一项针对长期 1 型糖尿病患者进行临床和代谢表型分析的全国前瞻性队列研究。
BMJ Open. 2024 Jun 19;14(6):e082453. doi: 10.1136/bmjopen-2023-082453.
6
Association of the American Heart Association's new "Life's Essential 8" with all-cause mortality in patients with chronic kidney disease: a cohort study from the NHANES 2009-2016.美国心脏协会的新“生命必需 8 项”与慢性肾脏病患者全因死亡率的关联:来自 NHANES 2009-2016 的队列研究。
BMC Public Health. 2024 Jun 19;24(1):1637. doi: 10.1186/s12889-024-19138-w.
7
Cardiovascular disease and cancer: shared risk factors and mechanisms.心血管疾病和癌症:共同的风险因素和机制。
Nat Rev Cardiol. 2024 Sep;21(9):617-631. doi: 10.1038/s41569-024-01017-x. Epub 2024 Apr 10.
8
Population-enriched innate immune variants may identify candidate gene targets at the intersection of cancer and cardio-metabolic disease.富含人群的固有免疫变异体可能在癌症和心脏代谢疾病的交叉点确定候选基因靶点。
Front Endocrinol (Lausanne). 2024 Mar 21;14:1286979. doi: 10.3389/fendo.2023.1286979. eCollection 2023.
9
Assessment of the effectiveness of weight-adjusted antibiotic administration, for reduced duration, in surgical prophylaxis of primary hip and knee arthroplasty.评估按体重调整抗生素给药在初次髋关节和膝关节置换术手术预防中缩短使用时长的有效性。
World J Orthop. 2024 Feb 18;15(2):170-179. doi: 10.5312/wjo.v15.i2.170.
10
Inhibition of Hyperglycemia and Hyperlipidemia by Blocking Toll-like Receptor 4: Comparison of Wild-Type and Toll-like Receptor 4 Gene Knockout Mice on Obesity and Diabetes Modeling.通过阻断Toll样受体4抑制高血糖和高血脂:野生型与Toll样受体4基因敲除小鼠在肥胖和糖尿病模型中的比较
Biology (Basel). 2024 Jan 22;13(1):63. doi: 10.3390/biology13010063.